HETHERINGTON GROUP PRACTICE
18 HETHERINGTON ROAD, LONDON
CKD 4
The percentage of patients on the CKD register with hypertension who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 52 | 71 | 73.2% | |
| CKD 4 | 2008 | 81 | 111 | 73.0% | |
| CKD 5 | 2009 | 23 | 31 | 74.2% | |
| CKD 5 | 2010 | 11 | 12 | 91.7% | |
| CKD 5 | 2011 | 14 | 15 | 93.3% | |
| CKD 5 | 2012 | 22 | 23 | 95.7% | |
| CKD 5 | 2013 | 19 | 23 | 82.6% | |
| CKD003 | 2014 | 19 | 20 | 95.0% | |
| CKD003 | 2015 | 17 | 19 | 89.5% | |
| NM84 | 2016 | 12 | 21 | 57.1% | |
| NM84 | 2017 | 12 | 18 | 66.7% | |
| NM84 | 2018 | 13 | 19 | 68.4% | |
| NM84 | 2019 | 11 | 16 | 68.8% | |
| NM84 | 2020 | 13 | 18 | 72.2% | |
| NM84 | 2022 | 12 | 17 | 70.6% | |
| NM84 | 2023 | 14 | 18 | 77.8% |
